体外膈肌起搏对AECOPD有创通气患者膈肌功能与撤机成功率的影响
该研究为前瞻性随机对照试验,纳入174例AECOPD有创通气患者,随机分为对照组和体外膈肌起搏(EDP)组各87例。主要终点撤机成功率EDP组显著高于对照组(93% vs 61%,P<0.05)。次要终点显示EDP组治疗后气道峰压、平台压、气道阻力、呼吸频率、心率、PaCO2更低,PaO2、氧合指数、膈肌移动度、膈肌增厚分数更高(均P<0.05),机械通气时间和ICU住院时间更短,28天ICU后死亡率和总死亡率更低(均P<0.05)。两组再插管率和ICU死亡率无显著差异。
要点
- EDP组撤机成功率93%(81/87)显著高于对照组61%(53/87),P<0.05。
- EDP组机械通气时间5.84±1.72天、ICU住院时间9.74±2.15天,均短于对照组(10.53±2.18天、14.38±3.06天)。
- EDP组28天ICU后死亡率7%(6/87)低于对照组20%(17/87),总死亡率9%(8/87)低于29%(25/87)。
- EDP组治疗后膈肌移动度3.49±0.56 mm、膈肌增厚分数(35.72±4.59)%均高于对照组(2.82±0.47 mm、(29.61±4.81)%)。
- 两组再插管率和ICU死亡率无统计学显著差异。
适用人群与场景
- 排除标准:原文未提及。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 对照组接受常规治疗;EDP组在常规治疗基础上联合体外膈肌起搏(EDP)干预。
- EDP的具体参数(频率、强度、时长、疗程)原文未提及。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:前瞻性随机对照试验(RCT),单中心(衡水市人民医院重症医学科),样本量174例,EDP组与对照组各87例。
- 主要终点:EDP组撤机成功率93%(81/87)高于对照组61%(53/87),P<0.05。
- 次要终点(治疗后组间比较,均P<0.05):气道峰压24.86±7.12 vs 31.03±8.05 cmH2O,平台压18.05±4.97 vs 23.08±6.21 cmH2O,气道阻力28.96±4.85 vs 34.12±5.61 cmH2O×L-1×s-1,呼吸频率20.13±2.46 vs 25.52±2.78次/min,心率71.32±3.68 vs 79.06±3.24次/min,PaCO2 45.36±7.54 vs
- 预后指标:机械通气时间5.84±1.72 vs 10.53±2.18天,ICU住院时间9.74±2.15 vs 14.38±3.06天,28天ICU后死亡率7%(6/87)vs 20%(17/87),总死亡率9%(8/87)vs 29%(25/87),均P<0.05;再插管率和ICU死亡率组间无显著差异。
证据类型、等级与局限
- 证据类型:前瞻性随机对照试验(RCT)。
- 证据等级或推荐强度:原文未提及。
- 局限:单中心研究;原文未提及盲法、样本量估算及EDP具体参数;原文未报告再插管率和ICU死亡率的具体数值。
对床旁实践的改变
- 对于AECOPD有创通气患者,在常规治疗基础上加用体外膈肌起搏可能提高撤机成功率、缩短机械通气时间和ICU住院时间,并可能降低28天ICU后死亡率和总死亡率。
- EDP的具体操作参数(频率、强度、时长、疗程)原文未提及,临床实施需参考设备说明或进一步研究。
- 不适用于原文未提及的人群(如排除标准未描述);再插管率和ICU死亡率未显示显著改善,不能据此认为EDP可降低所有死亡风险。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate whether the addition of external diaphragmatic pacing (EDP) to standard therapy can effectively improve diaphragmatic dysfunction in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) requiring invasive mechanical ventilation, and increase the likelihood of successful weaning.
METHODS: A prospective randomized controlled trial (RCT) was conducted. A total of 174 patients with AECOPD undergoing invasive mechanical ventilation who were admitted to the Department of Critical Care Medicine of Hengshui People's Hospital from November 1, 2022 to January 31, 2025 were enrolled. Patients were divided into a control group and an EDP group using a block randomization method, with 87 patients in each group. The control group received conventional therapy; the EDP group received conventional treatment combined with EDP. Baseline characteristics, primary outcome, and secondary outcomes were collected and compared between the two groups. The primary outcome was weaning success rate. Secondary outcomes included respiratory function parameters (peak airway pressure, plateau pressure, airway resistance, and respiratory rate), heart rate, arterial blood gas results [partial pressure of arterial carbon dioxide (PaCO2), partial pressure of arterial oxygen (PaO2), and oxygenation index (PaO2/FiO2)], diaphragmatic function [diaphragmatic excursion (DE) and diaphragmatic thickening fraction (DTF)], and prognostic indicators [duration of mechanical ventilation, intensive care unit (ICU) length of stay, reintubation rate, ICU mortality, 28-day post-ICU discharge mortality, and overall mortality].
RESULTS: There were no statistically significant differences in baseline characteristics such as gender, age, body mass index (BMI), COPD duration, comorbidities, PaO2/FiO2, Acute Physiology and Chronic Health Evaluation II(APACHE II), and Sequential Organ Failure Assessment (SOFA) between the two groups. In terms of the primary outcome, the weaning success rate after treatment in the EDP group was higher than that in the control group [93% (81/87) vs. 61% (53/87), P<0.05]. Regarding secondary outcomes, there were no statistically significant differences in airway peak pressure, plateau pressure, airway resistance, respiratory rate, heart rate, PaCO2, PaO2, PaO2/FiO2, DE, and DTF between the two groups before treatment. However, after treatment, all these parameters showed improvement, with more pronounced changes in the EDP group compared to the control group [peak airway pressure (cmH2O, 1 cmH2O=0.098 kPa): 24.86±7.12 vs. 31.03±8.05, plateau pressure (cmH2O): 18.05±4.97 vs. 23.08±6.21, airway resistance (cmH2O×L-1×s-1): 28.96±4.85 vs. 34.12±5.61, respiratory rate (breaths/min): 20.13±2.46 vs. 25.52±2.78, heart rate (beats/min): 71.32±3.68 vs. 79.06±3.24, PaCO2 (mmHg, 1 mmHg=0.133 kPa): 45.36±7.54 vs. 49.81±8.05, PaO2 (mmHg): 86.07±7.82 vs. 82.18±8.14, PaO2/FiO2 (mmHg): 253.57±51.96 vs. 201.83±45.37, DE (mm): 3.49±0.56 vs. 2.82±0.47, DTF: (35.72±4.59)% vs. (29.61±4.81)%, all P<0.05]. In addition, the duration of mechanical ventilation (days: 5.84±1.72 vs. 10.53±2.18) and length of ICU stay (days: 9.74±2.15 vs. 14.38±3.06) in the EDP group were shorter than those in the control group, and the 28-day post-ICU discharge mortality [7% (6/87) vs. 20% (17/87)] and overall mortality [9% (8/87) vs. 29% (25/87)] in the EDP group were lower than those in the control group (all P<0.05). However, there were no statistically significant differences between the two groups in reintubation rate or ICU mortality.
CONCLUSIONS: EDP intervention can significantly improve diaphragmatic function, reduce airway pressure and respiratory rate, shorten the duration of mechanical ventilation and length of ICU stay, increase weaning success rate, and reduce mortality. Thus, it provides high-quality, evidence-based support with clinical translational value for this high-risk patient population.
参考来源
- Guo C, Du Y, Xiao Q, et al. [Effect of external diaphragmatic pacing on diaphragmatic function and weaning success rate in patients with acute exacerbations of chronic obstructive pulmonary disease undergoing invasive mechanical ventilation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42427323. doi:10.3760/cma.j.cn121430-20251215-00606
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。